Icon Contactez-nous

Publications

HEVA > Publications > A multi-center evaluation of clinical pathways cost and time using real-life data in patients treated for their breast cancer by Trastuzumab intravenous and subcutaneous in day sessions

A multi-center evaluation of clinical pathways cost and time using real-life data in patients treated for their breast cancer by Trastuzumab intravenous and subcutaneous in day sessions

PMSI Oncologie poster
Auteurs: C. Blein, C. Bernard-Marty, V. Priou, M-C. Borg, M-A. Mouret-Reynier, G. Lebozec, J-F. Tournamille, A. Jaffre, N. Perez-staub, R. Alfonsi, N. Bahmad, H. Attar-Rabia
Date de publication: 10 novembre 2018
Accéder à la publication